Infectious Disease Diagnostics Market by Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza), End User - Global Forecast to 2026

Infectious Disease Diagnostics Market by Product (Reagents, Assays, Instrument), Test (Laboratory, POC), Technology (Immunodiagnostics, Microbiology, PCR, NGS, INAAT), Disease (COVID-19, Hepatitis, HAI, HIV, Influenza), End User - Global Forecast to 2026

The global infectious disease diagnostics market size is projected to reach USD 39.8billion by 2026 from USD 28.1billion in 2021, at a CAGR of 7.2% during the forecast period. Market growth is driven by factors such as global prevalence of infectious diseases & onset of COVID-19 and the growing awareness for early disease diagnosis, shift in focus from centralized laboratories to decentralized POC testing and rising technological advancements. On the other hand, an unfavorable reimbursement scenario is expected to limit market growth to a certain extent in the coming years.

“The reagents, kits, and consumablesaccounted for the highest growth rate in theinfectious disease diagnostics market, byproduct& service, during the forecast period”
The infectious disease diagnostics market is segmented into reagents, kits, and consumables; instruments; and software & services. The reagents, kits, and consumables segment accounted for the highest growth rate in the infectious disease diagnostics market in 2020. The requirement of reagents, kits and consumables in large numbers compared to instrumentsis the main factor contributing to this segment's high growth rate. This segment's market growth can also be attributed to repeat purchases of reagents, kits, and consumables compared to instruments.

“HAIs segment accounted for the highest CAGR”
Based on the disease type, the infectious disease diagnostics market is segmented into COVID-19, HIV, HAIs, hepatitis, CT/NG, HPV, TB, influenza, and other infectious diseases. The increasing number of cases and the availability of many COVID-19 diagnostic tests are driving the growth of this market. In 2020, the HAIs segment accounted for the highest CAGR.

“Diagnostic Laboratoriessegment accounted for the highest CAGR”
Based on end-users, the infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, academic research institutes, and other end users. In 2020, the diagnostic laboratories segment accounted for the highest CAGR. This can be attributed to increased test volume of infectious diseases and strengthening healthcare infrastructure for efficient disease diagnosis and treatment.

“Asia Pacific: The fastest-growing regioninfectious disease diagnostics market”
The global infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Factors such as government efforts to increase awareness about the early detection of diseases and regular health check-ups, continuously rising healthcare expenditure, increasing number of hospitals, clinical diagnostic laboratories in India and China, and strengthening research base for diagnostic procedures across India, China, and Japan are driving the growth of the infectious disease diagnosticsmarket in this region.

The primary interviews conducted for this report can be categorized as follows:
By Company Type: Tier 1 - 20%, Tier 2 - 45%,and Tier 3 -35%
By Designation: C-level - 30%, D-level - 20%, and Others - 50%
By Region: North America -36%, Europe - 25%, Asia Pacific - 27%, Latin America – 9%, and the Middle East & Africa – 3%

Lits of Companies Profiled in the Report:
Abbott Laboratories (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
bioMérieux SA (France)
Thermo Fisher Scientific Inc. (US)
Danaher Corporation (US)
QuidelCorporation(US)
Hologic, Inc. (US)
PerkinElmer Inc. (US)
Bio-Rad Laboratories, Inc. (US)
QIAGEN (Netherlands)
Siemens Healthineers AG (Germany)
Becton, Dickinson and Company (US)
DiaSorin S.p.A (Italy)
Grifols S.A. (Spain)
Sysmex Corporation (Japan)
Ortho Clinical Diagnostics (US)
Genetic Signatures (Australia)
Luminex Corporation (US)
Meridian Bioscience (US)
OraSure Technologies (US)
Trinity Biotech Plc. (Ireland)
Chembio Diagnostic Systems, Inc. (US)
Seegene Inc. (South Korea)
Co-Diagnostics, Inc. (US)
ELITechGroup (France)
Epitope Diagnostics, Inc. (US)
Trivitron Healthcare (India)
Meril Life Sciences Pvt. Ltd. (India)
InBios International, Inc. (US)
ABACUS Diagnostica Oy (Finland)

Research Coverage:
This report provides a detailed picture of the global infectious disease diagnostics market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service, test of testing, technology,disease type, end user, and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall infectious disease diagnostics market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • INCLUSIONS & EXCLUSIONS OF THE STUDY
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
    • RESEARCH APPROACH
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
    • RISK ASSESSMENT
      • Table RISK ASSESSMENT: INFECTIOUS DISEASE DIAGNOSTICS MARKET
    • COVID-19 HEALTH ASSESSMENT
    • COVID-19 ECONOMIC ASSESSMENT
    • ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE INFECTIOUS DISEASE DIAGNOSTICS MARKET
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
      • COVID-19 IMPACT ANALYSIS
    • PRICING ANALYSIS
      • Table PRICING ANALYSIS OF INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS (2021)
    • PATENT ANALYSIS
      • POLYMERASE CHAIN REACTION
      • IMMUNODIAGNOSTICS
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS
    • PORTER'S FIVE FORCES ANALYSIS
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • THREAT FROM SUBSTITUTES
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
    • PESTLE ANALYSIS
    • REGULATORY LANDSCAPE
      • NORTH AMERICA
      • EUROPE
      • ASIA PACIFIC
      • LATIN AMERICA
      • MIDDLE EAST
      • AFRICA
    • TRADE ANALYSIS
      • TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
        • Table IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016„Ÿ 2020 (USD MILLION)
        • Table IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2016„Ÿ 2020 (TONS)
      • TRADE ANALYSIS FOR CULTURE MEDIA
        • Table IMPORT DATA FOR CULTURE MEDIA, BY COUNTRY, 2016„Ÿ 2020 (USD MILLION)
        • Table IMPORT DATA FOR CULTURE MEDIA, BY COUNTRY, 2016„Ÿ 2020 (TONS)
    • TECHNOLOGY ANALYSIS
    • YC–YCC SHIFT
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
    • REAGENTS, KITS, AND CONSUMABLES
      • REPEAT PURCHASE OF REAGENTS, KITS, AND CONSUMABLES DRIVES THE MARKET GROWTH
        • Table INFECTIOUS DISEASE DIAGNOSTICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
    • INSTRUMENTS
      • INCREASING NEED FOR FASTER & ACCURATE TEST RESULTS TO PROPEL THE MARKET GROWTH
        • Table KEY PRODUCTS IN THE INSTRUMENTS MARKET
        • Table INFECTIOUS DISEASE DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
    • SOFTWARE & SERVICES
      • NEED TO DELIVER ACCURATE AND TIMELY ANALYSIS OF DIAGNOSTIC TESTS
        • Table INFECTIOUS DISEASE DIAGNOSTICS SOFTWARE & SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TYPE OF TESTING
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TYPE OF TESTING, 2019–2026 (USD MILLION)
    • LABORATORY TESTING
      • OUTBREAK OF COVID-19 DRIVES DEMAND FOR LAB TESTS
        • Table LABORATORY TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)
    • POC TESTING
      • THE INCREASING ADOPTION OF POC TECHNOLOGIES DRIVES THE GROWTH OF THIS SEGMENT
        • Table POC TESTING MARKET, BY REGION, 2019–2026 (USD MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
    • IMMUNODIAGNOSTICS
      • RISING PREVALENCE OF INFECTIOUS DISEASES AND DEMAND FOR COVID-19 DIAGNOSTICS DRIVE MARKET GROWTH
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2019–2026 (USD MILLION)
    • POLYMERASE CHAIN REACTION
      • THE GROWING USE OF RT-PCR IN COVID-19 TESTS IS A MAJOR GROWTH DRIVER FOR THIS SEGMENT
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR PCR, BY REGION, 2019–2026 (USD MILLION)
    • CLINICAL MICROBIOLOGY
      • GROWING ADOPTION BY RESEARCHERS AND ACADEMIA IS EXPECTED TO DRIVE MARKET GROWTH
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CLINICAL MICROBIOLOGY, BY REGION, 2019–2026 (USD MILLION)
    • ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
      • COST-BENEFITS OF INAAT DRIVE DEMAND FOR THE TECHNOLOGY
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INAAT, BY REGION, 2019–2026 (USD MILLION)
    • DNA SEQUENCING & NGS
      • INCREASING FOCUS ON PERSONALIZED MEDICINE IS A GROWTH DRIVER FOR THIS SEGMENT
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DNA SEQUENCING & NGS, BY REGION, 2019–2026 (USD MILLION)
    • DNA MICROARRAYS
      • GROWING AWARENESS ABOUT ADVANCED TECHNOLOGIES TO DRIVE MARKET GROWTH
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DNA MICROARRAYS, BY REGION, 2019–2026 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2019–2026 (USD MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
    • COVID-19
      • HIGH AND GROWING CASE PREVALENCE ENSURES DEMAND FOR COVID-19 DIAGNOSTICS
        • Table DISTRIBUTION OF CASES BY COUNTRY
        • Table COVID-19 DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table COVID-19 DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
        • Table COVID-19 DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
    • HUMAN IMMUNODEFICIENCY VIRUS
      • THE HIGH PREVALENCE OF HIV WILL DRIVE THE MARKET GROWTH FOR THIS SEGMENT
        • Table HIV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table HIV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
    • HOSPITAL-ACQUIRED INFECTIONS
      • THE RISING BURDEN OF MRSA INFECTIONS IS A KEY FACTOR DRIVING THE MARKET GROWTH FOR THIS SEGMENT
        • Table HAI DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table HAI DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
    • HEPATITIS
      • THE GLOBAL PREVALENCE OF HEPATITIS IS A KEY FACTOR DRIVING MARKET GROWTH
        • Table HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
        • Table HEPATITIS DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
    • CHLAMYDIA TRACHOMATIS GENITAL INFECTIONS AND GONORRHEA
      • CT/NG INFECTIONS ARE THE MOST COMMON STDS
        • Table CT/NG DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table CT/NG DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
    • HUMAN PAPILLOMA VIRUS
      • TECHNOLOGICAL ADVANCEMENTS SUCH AS RAPID HPV DIAGNOSTICS TO DRIVE THE MARKET GROWTH FOR THIS SEGMENT
        • Table HPV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table HPV DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
    • TUBERCULOSIS
      • THE INCREASING BURDEN OF TB GLOBALLY TO DRIVE THE MARKET GROWTH OF THIS SEGMENT
        • Table TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table TUBERCULOSIS DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
        • Table TUBERCULOSIS DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
    • INFLUENZA
      • RISING FOCUS ON CONTAINING THE SPREAD OF INFLUENZA
        • Table INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
        • Table INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2019–2026 (MILLION TESTS)
        • Table INFLUENZA DIAGNOSTICS MARKET, BY METHOD, 2019–2026 (USD MILLION)
    • OTHER INFECTIOUS DISEASES
      • Table OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • DIAGNOSTIC LABORATORIES
      • INCREASING OUTSOURCING TO DIAGNOSTIC LABORATORIES FOR REDUCED COSTS DRIVES MARKET GROWTH
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
    • HOSPITALS & CLINICS
      • HOSPITALS & CLINICS SHOW INCREASING ADOPTION RATE OF INFECTIOUS DISEASE DIAGNOSTIC TOOLS
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2026 (USD MILLION)
    • ACADEMIC RESEARCH INSTITUTES
      • FOCUS ON DEVELOPING INNOVATIVE TESTS DRIVES MARKET GROWTH
        • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
    • OTHER END USERS
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2019–2026 (USD MILLION)
  • INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
      • Table NORTH AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • US
        • Table US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table US: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • CANADA
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table CANADA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • EUROPE
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
      • Table EUROPE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • GERMANY
        • Table GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table GERMANY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • ITALY
        • Table ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table ITALY: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • FRANCE
        • Table FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table FRANCE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • SPAIN
        • Table SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table SPAIN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • UK
        • Table UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table UK: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table ROE: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      • Table APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
      • Table APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
      • Table APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
      • Table APAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • CHINA
        • Table CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table CHINA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • JAPAN
        • Table JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table JAPAN: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • INDIA
        • Table INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table INDIA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table ROAPAC: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • LATIN AMERICA
      • RISING DISEASE PREVALENCE AND HEALTHCARE EXPENDITURE HAVE DRAWN FOREIGN PLAYERS TO LATAM MARKETS
        • Table LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table LATIN AMERICA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS WILL SUPPORT MARKET GROWTH
        • Table MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
        • Table MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
        • Table MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE, 2019–2026 (USD MILLION)
        • Table MEA: INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • MARKET SHARE ANALYSIS
      • INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING, BY DISEASE TYPE
        • Table GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HEPATITIS, BY KEY PLAYER, 2020
        • Table GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HIV, BY KEY PLAYER, 2020
        • Table GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HPV, BY KEY PLAYER, 2020
        • Table GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR INFLUENZA, BY KEY PLAYER, 2020
        • Table GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COVID-19, BY KEY PLAYER, 2020
    • COMPANY EVALUATION QUADRANT
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2020)
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF TOP PLAYERS
    • COMPETITIVE SCENARIO
      • MARKET EVALUATION MATRIX, 2018–2020
      • INFECTIOUS DISEASE DIAGNOSTICS: PRODUCT LAUNCHES & APPROVALS
        • Table KEY PRODUCT LAUNCHES & APPROVALS
      • INFECTIOUS DISEASE DIAGNOSTICS: DEALS
        • Table KEY DEALS
      • INFECTIOUS DISEASE DIAGNOSTICS: OTHER DEVELOPMENTS
        • Table OTHER KEY DEVELOPMENTS
  • COMPANY PROFILES
    • KEY PLAYERS
      • ABBOTT LABORATORIES
        • Table ABBOTT LABORATORIES: BUSINESS OVERVIEW
      • F. HOFFMANN-LA ROCHE
        • Table F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW
      • BIOMÉRIEUX SA
        • Table BIOMÉRIEUX SA: BUSINESS OVERVIEW
      • THERMO FISHER SCIENTIFIC
        • Table THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
      • DANAHER CORPORATION
        • Table DANAHER CORPORATION: BUSINESS OVERVIEW
      • QUIDEL CORPORATION
        • Table QUIDEL CORPORATION: BUSINESS OVERVIEW
      • HOLOGIC
        • Table HOLOGIC: BUSINESS OVERVIEW
      • PERKINELMER
        • Table PERKINELMER: BUSINESS OVERVIEW
      • BECTON, DICKINSON AND COMPANY
        • Table BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
      • SIEMENS HEALTHINEERS AG
        • Table SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
      • DIASORIN S.P.A
        • Table DIASORIN S.P.A: BUSINESS OVERVIEW
      • BIO-RAD LABORATORIES
        • Table BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
      • QIAGEN
        • Table QIAGEN: BUSINESS OVERVIEW
      • GRIFOLS S.A.
        • Table GRIFOLS S.A.: BUSINESS OVERVIEW
      • ORTHO CLINICAL DIAGNOSTICS
        • Table ORTHO CLINICAL DIAGNOSTICS: BUSINESS OVERVIEW
      • SYSMEX CORPORATION
        • Table SYSMEX CORPORATION: BUSINESS OVERVIEW
    • OTHER PLAYERS
      • LUMINEX CORPORATION
      • MERIDIAN BIOSCIENCE
      • TRINITY BIOTECH
      • CHEMBIO DIAGNOSTIC SYSTEMS
      • ORASURE TECHNOLOGIES
      • SEEGENE
      • CO-DIAGNOSTICS
      • GENETIC SIGNATURES
      • EPITOPE DIAGNOSTICS
      • TRIVITRON HEALTHCARE
      • ELITECHGROUP
      • MERIL LIFESCIENCES PVT. LTD.
      • INBIOS INTERNATIONAL
      • ABACUS DIAGNOSTICA OY
  • APPENDIX
    • INSIGHTS FROM INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings